| RS1554304957 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554304974 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1554304979 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome |
| RS1554305000 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554305006 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554305071 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1554305719 |
CRPPA
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS1554305880 |
CYP21A2
|
Health Risk |
Pathogenic/Likely pathogenic |
ADRENAL HYPERPLASIA, CONGENITAL |
| RS1554305937 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554306031 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS1554306093 |
GLI3
|
Health Risk |
Pathogenic |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS1554306094 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1554306288 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1554306353 |
PMS2
|
Health Risk |
Likely pathogenic |
Endometrial carcinoma, Endometrial carcinoma |
| RS1554306391 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554306445 |
PMS2
|
Health Risk |
Pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1554306525 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1554306528 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS1554306605 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS1554306620 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1554308513 |
GRM1
|
Health Risk |
Likely pathogenic |
Spinocerebellar ataxia 44, Spinocerebellar ataxia 44 |
| RS1554308880 |
PMS2
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Lynch syndrome |
| RS1554309080 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1554309086 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1554309093 |
FIG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4J |
| RS1554309352 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1554310169 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554310242 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1554310330 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1554310600 |
TMEM106B
|
Health Risk |
Pathogenic/Likely pathogenic |
Leukodystrophy, hypomyelinating |
| RS1554311394 |
CCN6
|
Health Risk |
Pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS1554312483 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1554312639 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554312687 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554313639 |
CCN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive pseudorheumatoid dysplasia, Progressive pseudorheumatoid dysplasia |
| RS1554314581 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS1554314595 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS1554314722 |
DNAH11
|
Health Risk |
Pathogenic |
— |
| RS1554314738 |
CCN6
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554315071 |
GLI3
|
Health Risk |
Pathogenic |
— |
| RS1554315373 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554316216 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554317002 |
CDK13
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Congenital heart defects |
| RS1554317158 |
GRM1
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia 44, Spinocerebellar ataxia 44 |
| RS1554317931 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Greig cephalopolysyndactyly syndrome |
| RS1554318136 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1554319117 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554320168 |
CRPPA
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS1554320205 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554320318 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1554321125 |
LAMA2
|
Health Risk |
Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1554322596 |
GSDME
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1554325967 |
GSDME
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1554326239 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554326263 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554326267 |
ASL
|
Health Risk |
Pathogenic/Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554326365 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554326755 |
CDK13
|
Health Risk |
Pathogenic |
Global developmental delay, Inborn genetic diseases |
| RS1554327181 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554327265 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554327284 |
AEBP1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic-like |
| RS1554327449 |
AEBP1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic-like |
| RS1554327573 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554327825 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554328206 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554328363 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554328381 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554328459 |
ASL
|
Health Risk |
Pathogenic/Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554328479 |
ASL
|
Health Risk |
Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1554328790 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS1554328952 |
PEX7
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Peroxisome biogenesis disorder 9B |
| RS1554328993 |
PEX7
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 9B, Peroxisome biogenesis disorder 9B |
| RS1554329068 |
ACTB
|
Health Risk |
Pathogenic |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS1554329078 |
ACTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Baraitser-Winter syndrome 1, Inborn genetic diseases |
| RS1554329113 |
ACTB
|
Health Risk |
Likely pathogenic |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS1554329182 |
ACTB
|
Health Risk |
Likely pathogenic |
ACTB Haploinsufficiency syndrome, ACTB Haploinsufficiency syndrome |
| RS1554329216 |
ACTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Baraitser-Winter syndrome 1, Cleft palate |
| RS1554329269 |
ACTB
|
Health Risk |
Likely pathogenic |
Baraitser-Winter syndrome 1, ACTB-related disorder |
| RS1554329281 |
ACTB
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Baraitser-Winter syndrome 1 |
| RS1554329317 |
ACTB
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Baraitser-Winter syndrome 1 |
| RS1554329331 |
ACTB
|
Health Risk |
Likely pathogenic |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS1554329516 |
ACTB
|
Health Risk |
Pathogenic |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS1554329523 |
ACTB
|
Health Risk |
Pathogenic |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS1554329546 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-Winter syndrome 1, ACTB-related disorder |
| RS1554329552 |
ACTB
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1554329554 |
ACTB
|
Health Risk |
Likely pathogenic |
— |
| RS1554329584 |
ACTB
|
Health Risk |
Pathogenic |
— |
| RS1554329646 |
ACTB
|
Health Risk |
Likely pathogenic |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS1554331461 |
PEX7
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS1554333636 |
PEX7
|
Health Risk |
Pathogenic |
Rhizomelic chondrodysplasia punctata type 1, Rhizomelic chondrodysplasia punctata type 1 |
| RS1554333853 |
CDK13
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1554333880 |
PEX7
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhizomelic chondrodysplasia punctata type 1, Peroxisome biogenesis disorder 9B |
| RS1554334255 |
TNXB
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Ehlers-Danlos syndrome due to tenascin-X deficiency |
| RS1554334301 |
HOXA2
|
Health Risk |
Pathogenic |
MICROTIA WITHOUT HEARING IMPAIRMENT, MICROTIA WITHOUT HEARING IMPAIRMENT |
| RS1554334433 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinism due to glucokinase deficiency, Maturity-onset diabetes of the young |
| RS1554334539 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1554334546 |
GCK
|
Health Risk |
Likely pathogenic/Likely risk allele |
Monogenic diabetes, GCK-related disorder |
| RS1554334579 |
GCK
|
Health Risk |
Likely pathogenic/Likely risk allele |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1554334610 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1554334613 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |